#NCSTJC Q5: The far-reaching effects of social determinants of health (SDOH) are increasingly appreciated but still poorly understood. How can we, as a profession, better understand the impact of SDOH on individuals and populations at risk for neurocritical illness?

Neurocritical Care Society #NCSTJC This is the question. And even more importantly, once we have achieved this understanding, how will we use it to create societal change to intervene and allow for more equitable outcomes for patients with stroke and ICH.

NEW research—Ceftriaxone to prevent early ventilator-associated #pneumonia in patients with #AcuteBrainInjury From Dahyot-Fizelier Claire & colleagues: bit.ly/3HzByR7

Looking forward to a great #NCSTJC discussion tomorrow on the PROPHY-VAP trial! Dahyot-Fizelier Claire Lasocki Kerforne Thomas Perrigault Pierre Fr Thomas Geeraerts karim Asehnoune CINOTTI Raphaël Yoann Launey Matthieu Boisson DF Olivier MIMOZ ATLANREA

Our #NCSTJC discussion on The Lancet Respiratory Medicine article begins at 9 AM CT today! Discussion questions will be posted hourly; connect with colleagues & discuss findings using #NCSTJC. 📑Read the article ow.ly/eVyq50QFkxR Moderator: Dr. Wendy Chang Wendy Chang

#NCSTJC on Dahyot-Fizelier Claire and colleagues' PROPHY-VAP trial is starting! Join us for the conversation on ventilator-associated pneumonia prevention practices in brain injury patients

Kicking off #NCSTJC with a poll ⬇️ 🔹Where do you practice if you use SOD/SDD for VAP prevention? 🔹If you don't use SOD/SDD, why not?

#NCSTJC Q2: Do you use prolonged IV antibiotics to prevent ventilator-associated pneumonia (VAP)? ow.ly/mwog50QFkxS Wendy Chang

Other resources used around the 🌏 apart from IDSA guidelines to diagnose #VAP? Join the #NCSTJC conversation 👇#IDtwitter #NeuroTwitter #TwitteRx

#NCSTJC Q4: Do you routinely screen for antibiotic-resistant organisms in your ICU patients? If so, which organisms and in what type of patients? ow.ly/YZf150QFoZU Wendy Chang

#NCSTJC Q5: The PROPHY-VAP trial found a single dose of ceftriaxone decreased the incidence of early VAP in patients with acute brain injury. Does this finding change your clinical practice? ow.ly/YZf150QFoZU Wendy Chang

#NCSTJC Q6: The authors also found that prophylactic ceftriaxone did not affect the incidence of late VAP in patients with acute brain injury. Does this finding change your clinical practice? ow.ly/YZf150QFoZU Wendy Chang

Do you prefer noninvasive vs invasive sampling? 🫁 Utilize biomarkers such as procalcitonin? 🩸 Use clinical decision tools like the Clinical Pulmonary Infection Score (CPIS)? 📋 #NCSTJC

Curious what concentration mannitol those who voted yes use? Mannitol 20% & 25% both higher osmolarity versus 3% NaCl 🤔

Exploring Phoenix and learning about sex, gender and diversity through #SAEM24 AWAEM SAEM ADIEM Academy #SGEM scavenger hunt

Standing room only at #NCS2024 session on Brain Trauma Foun. penetrating #TBI guidelines. Long awaited with useful algorithms including tool for assessing futility. Most importantly, advocates for aggressive surgical treatment and acknowledges challenges with prognostication.

🧠 Do you care for patients with acute brain injuries? 🫁 What is your sedation strategy with mechanical ventilation in these patients? Join the #NCSVJC discussion to learn more about practice variations worldwide and impact on outcomes!

Calling our #NCSPharmacy #PharmICU colleagues to weigh in on #NCSVJC discussion!